Literature DB >> 18940293

Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis.

T Jared Bunch1, Douglas L Packer, Arshad Jahangir, G Richard Locke, Nicholas J Talley, Bernard J Gersh, Ranjini R Roy, David O Hodge, Samuel J Asirvatham.   

Abstract

The mechanisms underlying the triggers and maintenance of atrial fibrillation (AF) are not fully understood. One potential unproved mechanism is that gastroesophageal reflux disease (GERD), in which acid reflux induces local and systemic inflammation, may increase triggered activity in the myocardium and pulmonary veins and increase AF risk. A self-report questionnaire was mailed to a random sample of 5,288 residents of Olmsted County, Minnesota, aged 25 to 74 years to assess the presence and frequency of GERD from 1988 to 1994. The long-term risk for AF over a period of 11.4 +/- 5.0 years was determined through review of clinical evaluations and the electrocardiographic database in those without previous AF. The average age was 53 +/- 17 years, and 2,571 subjects (49%) were man. Of these patients, 741 developed AF (cumulative probability of AF at 18 years 20%, 95% confidence interval [CI] 17% to 22%). Age (hazard ratio [HR] 1.09, 95% CI 1.08 to 1.10, p <0.001), male gender (HR 1.81, 95% CI 1.53 to 2.14, p <0.001), hypertension (HR 1.36, 95% CI 1.14 to 1.61, p = 0.0006), and heart failure (HR 1.74, 95% CI 1.16 to 2.60, p = 0.007) were independently associated with the risk of AF. The presence of any GERD was not associated with risk for AF (HR 0.81, 95% CI 0.68 to 0.96, p = 0.014) after adjustment for other risk factors. The frequency of GERD did not significantly affect the risk for AF, although patients with more frequent GERD had a slightly higher AF risk. Esophagitis increased the risk for AF (HR 1.94, 95% CI 1.35 to 2.78, p <0.001), but the association did not persist when accounting for other risk factors (p = 0.72). In conclusion, in this large population-based study of patients surveyed for GERD, no association was found with the presence or frequency of symptoms and AF. Patients with esophagitis were more likely to develop AF, although this association requires further study.

Entities:  

Mesh:

Year:  2008        PMID: 18940293      PMCID: PMC2895499          DOI: 10.1016/j.amjcard.2008.06.048

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

2.  Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders.

Authors:  P O Ettinger; C F Wu; C De La Cruz; A B Weisse; S S Ahmed; T J Regan
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

3.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

4.  Reflux esophagitis revisited: prospective analysis of radiologic accuracy.

Authors:  D J Ott; W C Wu; D W Gelfand
Journal:  Gastrointest Radiol       Date:  1981-01-15

Review 5.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.

Authors:  Tim T Issac; Hisham Dokainish; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

6.  Barium radiology: a sensitive test for gastro-oesophageal reflux.

Authors:  R J Sellar; J S De Caestecker; R C Heading
Journal:  Clin Radiol       Date:  1987-05       Impact factor: 2.350

7.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

8.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

9.  Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.

Authors:  S M Harding; J E Richter; M R Guzzo; C A Schan; R W Alexander; L A Bradley
Journal:  Am J Med       Date:  1996-04       Impact factor: 4.965

10.  The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.

Authors:  P E Carson; G R Johnson; W B Dunkman; R D Fletcher; L Farrell; J N Cohn
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

View more
  12 in total

1.  Is there a link between gastroesophageal reflux disease and atrial fibrillation?

Authors:  Jeffrey S Kunz; Brian Hemann; J Edwin Atwood; Jeffrey Jackson; Timothy Wu; Carolyn Hamm
Journal:  Clin Cardiol       Date:  2009-10       Impact factor: 2.882

2.  Gut To Heart: Acid Reflux Disease In Atrial Fibrillation And The Role Of Proton Pump Inhibitor.

Authors:  Mohit K Turagam; Poonam Velagapudi
Journal:  J Atr Fibrillation       Date:  2014-10-31

3.  Hiatal Hernia Is Associated With an Increased Prevalence of Atrial Fibrillation in Young Patients.

Authors:  Ranjini R Roy; Sandeep Sagar; T Jared Bunch; Wahaj Aman; Daniel J Crusan; Komandoor Srivathsan; Samuel J Asirvatham; Win K Shen; Arshad Jahangir
Journal:  J Atr Fibrillation       Date:  2013-08-31

4.  Objective Evaluation of Gastroesophageal Reflux Disease in Patients with Paroxysmal Atrial Fibrillation.

Authors:  Enia Lucia Coutinho; Fernando A M Herbella; Carlos Alexandre Volponi Lovato; Marco G Patti; Francisco Schlottmann; Angelo Amato Vincenzo de Paola
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

5.  Voltage-based device tracking in a 1.5 Tesla MRI during imaging: initial validation in swine models.

Authors:  Ehud J Schmidt; Zion T H Tse; Tobias R Reichlin; Gregory F Michaud; Ronald D Watkins; Kim Butts-Pauly; Raymond Y Kwong; William Stevenson; Jeffrey Schweitzer; Israel Byrd; Charles L Dumoulin
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668

6.  Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome-the heart to gut connection!

Authors:  Yeruva Madhu Reddy; Dhssraj Singh; Darbhamulla Nagarajan; Jayasree Pillarisetti; Mazda Biria; Hemant Boolani; Martin Emert; Vineela Chikkam; Kay Ryschon; James Vacek; Sudha Bommana; Donita Atkins; Atul Verma; Mojtaba Olyaee; Buddhadeb Dawn; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2013-06-06       Impact factor: 1.900

Review 7.  Atrial fibrillation in patients with gastroesophageal reflux disease: a comprehensive review.

Authors:  Crina Roman; Stanislas Bruley des Varannes; Lucian Muresan; Alina Picos; Dan L Dumitrascu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

8.  Gastroesophageal reflux disease and atrial fibrillation: a nationwide population-based study.

Authors:  Chin-Chou Huang; Wan-Leong Chan; Jiing-Chyuan Luo; Yu-Chun Chen; Tzeng-Ji Chen; Chia-Min Chung; Po-Hsun Huang; Shing-Jong Lin; Jaw-Wen Chen; Hsin-Bang Leu
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?

Authors:  Jae Jin Hwang; Dong Ho Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

Review 10.  Atrial Fibrillation: The Science behind Its Defiance.

Authors:  Maureen E Czick; Christine L Shapter; David I Silverman
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.